Specific binding of Fyn and phosphatidylinositol 3‐kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains
Authors:
- 1 October 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (10) , 2978-2984
Abstract
CD 19 is a B cell surface protein capable of forming non‐covalent molecular complexes with a number of other B cell surface proteins including the CD21/CD81/Leu‐13 complex as well as with surface immunoglobulin. CD19 tyrosine phosphorylation increases after B cell activation, and is proposed to play a role in signal transduction through its cytoplasmic domain, which contains nine tyrosine residues. Several second messenger proteins have been shown to immunoprecipitate with CD 19, including p59 Fyn (Fyn), p59 Lyn (Lyn) and phosphatidylinositol‐3 kinase (PI‐3 kinase). These associations are predicted to occur via the src‐homology 2 (SH2) domains of the second messenger proteins. Two of the cytoplasmic tyrosines in the CD 19 cytoplasmic region contain the consensus binding sequence for the PI‐3 kinase SH2 domain (YPO4‐X‐X‐M). However, the reported consensus binding sequence for the Fyn and Lyn SH2 domains (YPO4‐X‐X‐I/L) is not found in CD 19. We investigated the capacity of CD 19 cytoplasmic tyrosines to bind both Fyn and PI‐3 kinase SH2‐domain fusion proteins. In activated B cells, both Fyn and PI‐3 kinase SH2‐domain fusion proteins precipitate CD 19. Using synthetic tyrosine‐phosphorylated peptides comprising each of the CD 19 cytoplasmic tyrosines and surrounding amino acids, we investigated the ability of the Fyn SH2 and PI‐3 kinase SH2 fusion proteins to bind to the different CD 19 cytoplasmic phosphotyrosine peptides. ELISA revealed that the two CD 19 cytoplasmic tyrosine residues contained within the Y‐X‐X‐M sequences (Y484 and Y515) bound preferentially to the PI‐3 kinase SH2‐domain fusion proteins. Two different tyrosines (Y405 and Y445) bound preferentially to the Fyn SH2‐domain fusion protein via a novel sequence, Y‐E‐N‐D/E, different from that previously reported for the Fyn SH2 domain. In precipitation studies, peptide Y484 was able to compete with tyrosine phosphorylated CD 19 specifically for binding to the PI‐3 kinase SH2 domain fusion proteins, while peptides Y405 and Y445 were able to compete specifically for binding to the Fyn SH2 domain fusion proteins. These results indicate that CD19 may be capable of binding both Fyn and PI‐3 kinase concurrently, suggesting a mechanism for CD 19 signal transduction, in which binding of PI‐3 kinase to the Fyn SH3 domain results in activation of PI‐3 kinase.Keywords
This publication has 49 references indexed in Scilit:
- Activation of Phosphatidylinositol-3′ Kinase by Src-Family Kinase SH3 Binding to the p85 SubunitScience, 1994
- The CR2/CD19 complex on human B cells contains the src-family kinase LynInternational Immunology, 1993
- CD19 of B Cells as a Surrogate Kinase Insert Region to Bind Phosphatidylinositol 3-KinaseScience, 1993
- Ethylcarbamoyl protection for cysteine in the preparation of peptide‐conjugate immunogensInternational Journal of Peptide and Protein Research, 1992
- Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathwaysCell, 1992
- CD19: Lowering the Threshold for Antigen Receptor Stimulation of B LymphocytesScience, 1992
- Binding of SH2 Domains of Phospholipase Cγ1, GAP, and Src to Activated Growth Factor ReceptorsScience, 1990
- Stimulation of protein tyrosine phosphorylation by the B-lymphocyte antigen receptorNature, 1990
- CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tail.Journal of Experimental Medicine, 1988
- Solid Phase Peptide Synthesis. I. The Synthesis of a TetrapeptideJournal of the American Chemical Society, 1963